Coronavirus Disease 2019 (COVID-19) Outbreak
The novel coronavirus disease, labeled by the World Health Organization (WHO) as COVID-19, was first reported in Wuhan, China, on December 31, 2019. Compared to the previously identified coronaviruses such as the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), the fatality rate of COVID-19 is substantially lower but it is more transmissible, in so far as it has spread to over 199 countries, infected more than 722,000 people, and claimed over 33,000 lives to date (Worldometer, March 30). As one of the game-changers of the past decade, nanotechnology holds great promise in offering innovative solutions to a wide range of problems regarding the prevention, diagnosis, and treatment of COVID-19, in which nanotechnologists undoubtedly play a key role and shoulder their social responsibility. This webpage covers the most recent advances of nanotechnology in fighting COVID-19. Read more ...
▌The colorimetric based #MIT technology can detect the #SARS_CoV_2 within 20 minutes using nanoparticle-bound #antibodies against a specific viral protein. | more
▌The first step in the clinical development of #Moderna's #mRNA vaccine against #SARS_CoV_2 (mRNA-1273) is being conducted by #NIH under its own Investigational New Drug application. | more
▌#mRNA technology has been widely used in many #nanotechnology_patents focusing on the #coronavirus (SARS / MERS) treatment approaches. | more
▌A vast majority of #nanotechnology_patents on #coronaviruses have focused on the #diagnostic methods based on #CRISPR technology. | more
▌The future of #therapeutics is potent biological drugs, many of which have #delivery challenges with respect to how much drug needs to be delivered to exactly where in the body, while minimizing #side_effects. | more
▌Around 5.2 percent (478 patents) of all #coronavirus related patents so far registered are in the field of #nanotechnology. | more
▌Tulane National Primate Research Center (TNPRC) is establishing a #COVID_19 research program to develop a #vaccine and test treatments against the virus. | more
▌Loading #antiviral agents on #graphene_oxide (GO) enhances its biocompatibility while reducing the cytotoxicity of both GO and the antiviral agents. | more
▌New #COVID_19 vaccine candidate has been developed using proprietary #recombinant_protein nanoparticle technology platform to generate antigens derived from the #coronavirus spike (S) protein. | more
▌Integrating a proprietary #nanorod technology into a #lateral_flow_test platform resulted in developing of a rapid screening test for the current #coronavirus, nCoV19. | more
▌Carbon #quantum_dots functionalized with boronic acid ligands can interfere with the function of #coronavirus S protein and significantly inhibit its entry into the host cells. | more
▌#Nanofiber based #N95_respirators can block out at least 95 percent of the airborne particles larger than 2.5 microns, including droplets carrying #viruses and #bacteria. | more
▌Due to their two-dimensional structure, sharp edges, and negatively charged surfaces, #graphene_oxide nanosheets are capable of interacting with microorganisms such as #bacteria and #viruses. | more
Nanotechnology vs. Coronavirus Latest Updates
Mar. 30, 2020 | RNA Interference Technology, Potential Treatment for Coronavirus Infection
Mar. 27, 2020 | China’s First Coronavirus Vaccine Delivered for Human Trials
Mar. 24, 2020 | Coronavirus: Nanotech Surface Sanitizes Milan with Nanomaterials Remaining Self-sterilized for Years
Mar. 23, 2020 | Europe’s Healthcare System Now Armed with 15-minute Coronavirus Test
Mar. 22, 2020 | Nanofiber-based Face Mask Preserves Its Filtering Function and Sturdiness After 20 Washes
Mar. 21, 2020 | USF’s Innovative Air Purifier Is Soon to Be Tested Against Coronavirus
Mar. 19, 2020 | MIT Spin-out Startup Develops Paper-based Rapid Test for COVID-19
Mar. 18, 2020 | Moderna Runs First Human Trial for Coronavirus Vaccine
Mar. 18, 2020 | A Nanotechnological Godsend: This Anti-coronavirus Spray Keeps Surfaces Sterile for FIVE Years!
Mar. 17, 2020 | Nanoparticles Cast New Light on Mysterious Coronavirus, Treatment Is Around the Corner
Mar. 16, 2020 | Nanopolymer-based Disinfectants Are Being Tested in Prague’s Public Transport to Fight COVID-19
Mar. 16, 2020 | Researchers of ICN2 to Run a European Project to Develop a Rapid COVID-19 Test Based on Nanobiosensors
Mar. 15, 2020 | Applications Welcome from Startups and SMEs with Innovative Solutions to Tackle Coronavirus Outbreak
Mar. 14, 2020 | Follow StatNano to Read the Latest Updates on Nanotechnology vs. Coronavirus
Mar. 11, 2020 | An Overview of Nanotechnology Patents Focusing on Coronaviruses
Mar. 07, 2020 | New Research Program for Developing Nanotechnology-based Rapid Test and Vaccine for Coronavirus
Mar. 03, 2020 | Novavax Deploys Its Nanoparticle Vaccine Technology to Fight Coronavirus
Mar. 02, 2020 | Synergistic Antiviral Activity of Graphene Oxide and Common Antiviral Agents
Feb. 25, 2020 | Nanotechnology Startup Develops Quick-response Lateral-flow Test for Coronavirus
Feb. 14, 2020 | Nanotechnology-enabled N95 Masks Can Halt the Spread of Coronavirus
Jan. 28, 2020 | Coronavirus Outbreak? No Worries, Nanotechnology Is There to Help!
Oct. 10, 2019 | A Nanotechnology Research Collaboration between Harvard University and Moderna
Nanotechnology Products for Fighting Coronavirus
[Please login or create a new account to view products.]
⃝ Detection Kit | Medical Supplies | View Products
⃝ Vaccine | Pharmaceuticals | View Products
⃝ Disinfecting Spray | Medical Supplies | View Products
⃝ Respiratory Mask | Medical Supplies | View Products
⃝ Anti-bacterial Cream | Medical Supplies | View Products
⃝ Anti-bacterial Solution | Medical Supplies | View Products
⃝ UV Disinfectant | Medical Supplies | View Products
⃝ Medical Cream | Pharmaceuticals | View Products
⃝ Wound Dressing | Medical Supplies | View Products
⃝ Disinfectant | Medical Supplies | View Products
⃝ Hand Sanitizer | Sanitizing/Sexual Well-being | View Products
⃝ Cream | Skin Care | View Products
⃝ Air Purifier | Air Remediation | View Products
⃝ Humidifier | Air Remediation | View Products
⃝ Water Treatment System | Water and Wastewater | View Products
⃝ Drinking water dispenser | Water and Wastewater | View Products
⃝ Automotive Anti-bacterial Spray | Maintenance | View Products
⃝ Anti-microbial Coating | Maintenance | View Products
⃝ Anti-bacterial Paint | Masonry Materials | View Products
⃝ Solution | Masonry Materials | View Products
⃝ Multifunctional Cleaners | Housecleaning | View Products
⃝ Washing Machine | Housecleaning | View Products
⃝ Dishwashing Detergent | Housecleaning | View Products
⃝ Mobile Cleaner | Housecleaning | View Products
⃝ Sheet And Pillowcase Sets | Home Textile | View Products
⃝ Textile Finishing Agent | Finishing Agents | View Products
⃝ Dietary Supplement | Supplements | View Products
Organizations Deploying Nanotechnology to Tackle Coronavirus
Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on novel lipid nanoparticle (LNP)-encapsulated mRNA vaccine against the COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein.
Novavax developed a novel Middle East Respiratory Syndrome (MERS) coronavirus vaccine candidate in 2013, post the identification of the first MERS coronavirus (MERS-CoV) in Saudi Arabia in 2012. The candidate is designed to primarily bind to the major surface S-protein and developed using the company’s recombinant nanoparticle vaccine technology. Novavax has produced several nanoparticle vaccine candidates for testing in animal models. The company aims to carry out human trials in 2020.
NanoViricides, a clinical-stage company, is working on developing a treatment for nCoV-2019 using its nanoviricide® technology. The company’s technology is used to develop ligands that can bind to the virus in the same way as a cognate receptor and attack various points of the virus. NanoViricides confirms it has been working on a treatment for the novel Wuhan coronavirus.
Alnylam Pharmaceuticals, Inc.
Alnylam is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines. Recent Alnylam advances in lung delivery technology suggest possible utility of siRNAs in targeting SARS-CoV-2 and other coronaviruses.
CanSino Biologics Inc.
CanSino Biologics Inc is an innovative biopharmaceutical company dedicated to exploring best solutions to the prevention of diseases through cutting edge research & development, advanced manufacturing and commercialization of innovative vaccine products. CanSino’s Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) candidate has been approved to enter into Phase 1 Clinical Trial.
Biopharmaceutical New Technologies (BioNTech) is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range infectious diseases including COVID-19. The company employs multiple mRNA delivery formulations, such as LPNs, each designed for different functions and optimized for therapeutic product needs based on the intended application and route of delivery.